Home | Volume 9

Retardation of atherosclerosis in immunocompetent apolipoprotein (apo) E-deficient mice following liver-directed administration of a [E1−, E3−, polymerase−] adenovirus vector containing the elongation factor-1α promoter driving expression of human apoE cDNA

Dr. George Dickson et. al.

Download as PDF : 04._Harris_et_al,_23-32.pdf : 485014 bytes


Previous Article: Circular dumbbell AP-1 and E2F decoy oligodeoxynucleotide based antiproliferative gene therapy
Next Article: A rational approach to the systemic treatment of cancer involving medium-term depletion of arginine
The Publication:
Retardation of atherosclerosis in immunocompetent apolipoprotein (apo) E-deficient mice following liver-directed administration of a [E1−, E3−, polymerase−] adenovirus vector containing the elongation factor-1α promoter driving expression of human apoE cDNA
is not formatted in HTML just yet, but will be available very soon!
Please view as a PDF: 04._Harris_et_al,_23-32.pdf in the meantime.